# Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

> **NCT04574089** · PHASE3 · RECRUITING · sponsor: **Peking University Shenzhen Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Vaginitis

## Interventions

- **DRUG:** Experimental: Baofukang Suppository 7 days
- **DRUG:** Experimental: Baofukang Suppository 14 days

## Key facts

- **NCT ID:** NCT04574089
- **Lead sponsor:** Peking University Shenzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04574089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04574089, "Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04574089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*